Introduction
============

*Para*-phenylenediamine (PPD), also known as 1,4-diaminobenzene, is a key primary precursor of the oxidative dyes used in hair coloring and tattoos ([@b1-mmr-12-01-0921],[@b2-mmr-12-01-0921]). However, accumulating evidence has suggested that this compound sensitizes skin to allergic reactions ([@b3-mmr-12-01-0921],[@b4-mmr-12-01-0921]). Further studies have identified that these allergic reactions predominantly occur due to PPD-mediated activation of dendritic cells ([@b5-mmr-12-01-0921]). Additionally, PPD is a potential carcinogen, which was reported to increase the risk of tumorigenesis in the kidney, liver, thyroid gland and urinary bladder in mice and rats ([@b6-mmr-12-01-0921],[@b7-mmr-12-01-0921]). In addition, *in vitro* studies have demonstrated that PPD induced reactive oxygen species (ROS)-mediated DNA damage in uroepithelial cells and activated p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase in Chang liver cells ([@b8-mmr-12-01-0921],[@b9-mmr-12-01-0921]). A case report demonstrated that PPD induced severe acute hair loss in females within six days of application ([@b10-mmr-12-01-0921]). However, it remains to be elucidated whether PPD contributes to hair loss by inducing damage to normal human hair dermal papilla cells (nHHDPCs).

MicroRNAs (miRNAs) are small (18--24 nucleotides) noncoding RNAs that repress the translation of target genes through imperfect base pairing to the 3′-untranslated region of their target mRNAs ([@b11-mmr-12-01-0921],[@b12-mmr-12-01-0921]). miRNAs have been reported to be key regulators of apoptosis, proliferation and differentiation ([@b13-mmr-12-01-0921]). Regarding the role of miRNA in hair, it has been reported that the expression levels of miRNA-31 (miR-31) were upregulated in the anagen phase of the hair growth cycle and controlled the expression levels of Krt16, Krt17, Dlx3 and Fgf10 ([@b14-mmr-12-01-0921]). In addition, miR-24 was reported to regulate the development of hair follicles by targeting the hair keratinocyte stemness regulator Tcf-3 ([@b15-mmr-12-01-0921]). Furthermore, a previous study demonstrated that Dicer, an miRNA-processing enzyme, was essential for the morphogenesis of hair follicles ([@b16-mmr-12-01-0921]).

The aim of the current study was to investigate the effects of PPD on cell growth, death and senescence in nHHDPCs. In addition, the role of PPD in the regulation of the expression profile and the mechanisms of specific miRNAs was evaluated using bioinformatics analysis.

Materials and methods
=====================

Cells and culture conditions
----------------------------

nHHDPCs (Innoprot, Biscay, Spain) were cultured in Dulbecco's modified Eagle's medium (Gibco Life Technologies, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (Gibco Life Technologies) and 1% penicillin-streptomycin (Gibco Life Technologies) at 37°C in an atmosphere of 5% CO~2~. PPD was purchased from Sigma-Aldrich (St. Louis, MO, USA).

Cell viability assay
--------------------

Cell viability was monitored using the water-soluble tetrazolium salt (WST-1) assay (EZ-Cytox Cell Viability Assay kit; ITSbio, Seoul, Korea). A total of 5×10^3^ nHHDPCs were seeded into 96-well plates and treated with various concentrations of PPD (0, 100, 200, 300, 400, 500 and 600 *μ*M) for 24 h. Following treatment, nHHDPCs were mixed with 10 *μ*l WST-1 solution and incubated at 37°C for 0.5 h. Cell viability was then determined by measuring absorbance at 450 nm using an iMark plate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Propidium iodide (PI)-based cell cycle analysis
-----------------------------------------------

The cell cycle was analyzed using PI (Sigma-Aldrich) staining of DNA. nHHDPCs were plated and treated with various concentrations of PPD (0, 200, 400 and 600 *μ*M) for 24 h. Cells were then trypsinized (using 0.25% trypsin-EDTA; Gibco Life Technologies), centrifuged (3,500 × g, 2 min), washed with phosphate-buffered saline (PBS; Gibco Life Technologies) and fixed in 70% ethanol (Merck Millipore, Darmstadt, Germany) at 4°C for 3 h. The fixed cells were incubated with staining solution \[50 *μ*g/ml PI, 0.1 *μ*g/ml RNase (Life Technologies, Grand Island, NY, USA) and 0.05% Triton X-100 (Sigma-Aldrich) in PBS\] at 37°C for 1 h and then analyzed using a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA). The mean PI fluorescence intensity was determined based on analysis of 10,000 cells using the FLH-2 detection channel (585±42 nm).

Detection of cellular senescence
--------------------------------

For the assessment of cellular senescence, nHHDPCs (2×10^6^) were seeded into 60-mm cell culture dishes and treated with 0 or 400 *μ*M PPD. Following 48 h of treatment, cells were fixed using Fixative solution (included in Senescence Detection kit; BioVision, Inc., Milpitas, CA, USA) and senescence-associated-β-galactosidase (SA-β-gal) activity was measured using the Staining Solution Mix, including Staining Solution, Staining Supplements and X-gal substrate for (SA-β-gal) within the Senescence Detection kit, according to the manufacturer's instructions. Cells stained for SA-β-gal were counted under a light microscope (CKX41; Olympus Corporation, Tokyo, USA) (magnification, ×200) and the percentage of SA-β-gal positive cells were calculated.

Detection of intracellular ROS
------------------------------

Staining for ROS in cultured cells was conducted using a 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA; Sigma-Aldrich) assay. Briefly, 2×10^6^ nHHDPCs were plated in 60-mm culture dishes and treated with PPD. Following treatment for 24 h, the cells were stained by adding DCF-DA to the culture medium to a final concentration of 20 *μ*M and then incubating for 1 h. Distribution of the stained cell population was determined using a FACSCalibur flow cytometer.

miRNA expression profiling
--------------------------

In order to analyze the miRNA expression profile, nHHDPCs (2×10^6^) were seeded into 60-mm culture dishes and treated with 400 *μ*M PPD. Following 24 h of treatment, total RNA was purified using TRIzol reagent (Life Technologies) according to the manufacturer's instructions. Total RNA was dephosphorylated and labeled with pCp-Cy3 using an Agilent miRNA Labeling kit (Agilent Technologies, Inc., Santa Clara, CA, USA). Labeled RNAs were hybridized using a SurePrint G3 Human v16 miRNA 8×60K microarray (Agilent Technologies, Inc.) at 65°C for 20 h. The miRNA expression profile was digitized using Feature Extraction version 10.7 software (Agilent Technologies). Fold changes in miRNA expression levels were determined using GeneSpring GX software, version 11.5 (Agilent Technologies).

Prediction of potential target genes of PPD-regulated miRNAs and gene ontology (GO) analysis
--------------------------------------------------------------------------------------------

Potential target genes of PPD-regulated miRNAs were predicted using the DNA Intelligent Analysis (DIANA) microT-CDS version 5.0 bioinformatics tool (<http://diana.cslab.ece.ntua.gr/>). GO of each putative target gene was identified using the Database for Annotation, Visualization and Integrated Discovery (DAVID) bioinformatics resource, version 6.7 (<http://david.abcc.ncifcrf.gov>). Target genes were categorized into four GO terms: Aging, skin development, apoptosis and cell proliferation. Furthermore, target gene-associated signaling pathways were determined using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway algorithm (<http://david.abcc.ncifcrf.gov/summary.jsp>) within the DAVID resource.

Statistical analyses
--------------------

Values are expressed as the mean ± standard error of the mean of three independent experiments. Statistical significance was determined by Student's t-test and P\<0.05 was considered to indicate a statistically significant difference between values.

Results
=======

PPD treatment reduces the proliferation rate of nHHDPCs
-------------------------------------------------------

Previous studies reported that exposure to \>250 *μ*M and \>60 *μ*M PPD resulted in considerable cytotoxicity in dendritic cells ([@b17-mmr-12-01-0921]) and keratinocytes ([@b18-mmr-12-01-0921]), respectively. Therefore, the current study aimed to determine the cytotoxic effects of PPD on nHHDPCs at concentrations of 0, 100, 200, 300, 400, 500 and 600 *μ*M using a WST-1-based cell viability assay. As shown in [Fig. 1](#f1-mmr-12-01-0921){ref-type="fig"}, the viability of nHHDPCs was significantly reduced following exposure to PPD for 24 h. Maximal toxicity was observed at 600 *μ*M, at which concentration cell viability was reduced to 58.33±2.39% of the control value (*n*=3; P\<0.05). The IC~25~ (a 25% reduction in viability) of PPD was 400 *μ*M, at which concentration cell viability was reduced to 74.42±6.08% of control value (P\<0.05) ([Fig. 1](#f1-mmr-12-01-0921){ref-type="fig"}).

PPD treatment increases cell death and cell cycle arrest in nHHDPCs
-------------------------------------------------------------------

The present study investigated whether PPD-induced loss of cell viability occurred due to cell cycle arrest and cell death. Cells were treated with PPD (0, 200, 400 and 600 *μ*M) for 24 h and the distribution of cells in the different cell cycle phases was analyzed using flow cytometry. As shown in [Fig. 2](#f2-mmr-12-01-0921){ref-type="fig"}, treatment with 200, 400 and 600 *μ*M PPD led to significant accumulation in the sub-G~1~ phase, compared with that of control DMSO-treated cells (P\<0.05). In addition, the proportion of cells in G~1~/G~2~ was significantly reduced by PPD (P\<0.05), indicating that PPD increased the G~2~ population. These data therefore demonstrated that PPD induced cell death and G~2~ arrest in nHHDPCs.

PPD treatment leads to the accumulation of intracellular ROS and senescence-like growth
---------------------------------------------------------------------------------------

Chye et al ([@b8-mmr-12-01-0921]) observed that PPD increased intracellular ROS and induced apoptosis in Chang normal human liver cells. Therefore, the current study investigated the effects of PPD on the regulation of intracellular ROS production in nHHDPCs. Intracellular ROS levels were determined using an DCF-DA probe, which is oxidized to fluorescent DCF in the presence of ROS. As presented in [Fig. 3A](#f3-mmr-12-01-0921){ref-type="fig"}, exposure to PPD resulted in a marked increase in fluorescent DCF-positive cells compared with that of the control cells, indicating that PPD increased intracellular ROS production in nHHDPCs. As ROS have been implicated in cellular senescence ([@b19-mmr-12-01-0921]), the present study investigated whether the PPD-mediated increase in ROS was associated with increased senescence by analyzing the activity of SA-β-gal, a marker of cellular senescence. Consistent with the observed ROS increase, PPD was identified to promote an increase in SA-β-gal activity ([Fig. 3B](#f3-mmr-12-01-0921){ref-type="fig"}), indicating that PPD induces cellular senescence in nHHDPCs.

Identification of differentially expressed miRNAs in PPD-treated nHHDPCs
------------------------------------------------------------------------

[Fig. 2](#f2-mmr-12-01-0921){ref-type="fig"} and [3](#f3-mmr-12-01-0921){ref-type="fig"} demonstrated that cell cycle arrest in G~2~ phase and PPD-mediated cell death were characterized by increased ROS production. Therefore, in order to determine whether ROS-mediated cell cycle arrest and cell death are associated with miRNA expression, miRNA microarray analysis was conducted using the SurePrint G3 Human v16 miRNA 8×60K microarray, which contained 2,006 human miRNA probes. Significant miRNAs exhibiting a ≥2.0-fold increase or reduction in expression were selected using GeneSpring GX software. As presented in [Table I](#tI-mmr-12-01-0921){ref-type="table"}, PPD differentially regulated the expression levels of 74 miRNAs. Notably, 16 of 74 miRNAs were significantly upregulated and 58 miRNAs were significantly downregulated. In particular, miR-425-3p exhibited the greatest increase in expression (230.60-fold) and miR-3656 the greatest reduction (112.15-fold), compared with the corresponding miRNAs in control cells. These results suggested that the PPD-mediated cellular effects were associated with alterations in expression of specific miRNAs.

Bioinformatic analysis of PPD-modulated miRNAs
----------------------------------------------

As miRNAs perform their biological functions through regulation of target mRNA translation ([@b11-mmr-12-01-0921]), the present study aimed to predict the target genes of the miRNAs deregulated in response to PPD. The biological functions of the upregulated and downregulated genes were then determined following categorization into the four groups: Aging, apoptosis, cell proliferation and skin development, using DAVID ([Tables II](#tII-mmr-12-01-0921){ref-type="table"} and [III](#tIII-mmr-12-01-0921){ref-type="table"}, respectively). In addition, in order to identify the specific signaling pathways of the deregulated miRNAs, the correlation between KEGG pathway-associated genes and the target genes of each miRNA were analyzed. The meaningful KEGG pathways with a value \>1% (percentage of target genes/total genes involved in each pathway) were selected. The analysis identified a wide distribution of cellular functions, which are presented in [Tables IV](#tIV-mmr-12-01-0921){ref-type="table"} and [V](#tV-mmr-12-01-0921){ref-type="table"}. The results indicated that the upregulated miRNAs were implicated in signaling pathways in cancer, ubiquitin-mediated proteolysis, melanogenesis, cell cycle, Wnt signaling, MAPK signaling, neurotrophin signaling, cell adhesion molecules (CAMs), long-term potentiation, natural killer cell-mediated cytotoxicity, calcium signaling, neuroactive ligand-receptor interactions, glycosphingolipid biosynthesis, arrhythmogenic right ventricular cardiomyopathy, axon guidance, ErbB signaling, gonadotropin-releasing hormone signaling, tight junctions and viral myocarditis ([Table IV](#tIV-mmr-12-01-0921){ref-type="table"}). In addition, PPD-induced downregulated miRNAs were implicated in signaling pathways in cancer, regulation of actin cytoskeleton, Wnt signaling, oocyte meiosis, glycerolipid metabolism, MAPK signaling, insulin signaling, chemokine signaling, cytokine-cytokine receptor interaction, Janus kinase-signal transducer and activator of transcription signaling, calcium signaling, mammalian target of rapamycin signaling, axon guidance, cell cycle, ubiquitin mediated proteolysis, regulation of actin cytoskeleton, ErbB signaling, melanogenesis, TGF-β signaling, vascular smooth muscle contraction, tight junction, neuroactive ligand-receptor interactions, CAMs, glycerophospholipid metabolism, adipocytokine signaling and neurotrophin signaling ([Table V](#tV-mmr-12-01-0921){ref-type="table"}).

Discussion
==========

Although PPD has been widely used in hair dyes and tattoos, previous studies have demonstrated that PPD may be an important etiological factor for allergic contact dermatitis ([@b20-mmr-12-01-0921],[@b21-mmr-12-01-0921]). However, the side effects of PPD in hair follicle cells remain to be fully elucidated. The results of the current study provided evidence for senescence and cell death as key responses of nHHDPCs to PPD. The senescence-associated alterations observed included G~2~ phase arrest and increases in ROS production as well as SA-β-gal activity. To the best of our knowledge, the present study was to first to report these responses in dermal papilla cells, although PPD-mediated hair loss has been described in a clinical report ([@b10-mmr-12-01-0921]). PPD was reported to promote apoptosis through oxidative stress-induced DNA damage in kidney and liver cells ([@b22-mmr-12-01-0921],[@b23-mmr-12-01-0921]). The data of the current study confirmed the apoptotic effect of PPD in dermal papilla cells; however, maximal toxicity was obtained at 600 *μ*M, which only increased the proportion of apoptotic cells 9.21%. The most notable observation in the present study was the implication of PPD in the induction of G~2~ phase arrest, cellular ROS production and senescence in dermal papilla cells. The proportion of cells in G~1~/G~2~ phase was significantly reduced at 400 *μ*M, at which concentration ROS production was increased by 50.61% compared with the control group. Consistent with the data described, 400 *μ*M PPD increased the number of senescent cells by 15.90%. It has been previously demonstrated that PPD increased intracellular ROS levels and induced apoptosis in Chang normal human liver cells ([@b8-mmr-12-01-0921]). In the present study, marked alterations in the levels of cell death and senescence were observed in dermal papilla cells following PPD treatment. The data collected indicated that PPD induced G~2~ arrest and ROS production, which in turn triggered cellular senescence leading to cell death in HHDPCs.

Under identical experimental conditions, the present study identified 74 miRNAs that were differentially expressed by ≥2-fold following PPD treatment in nHHDPCs. Among these, 16 miRNAs were significantly upregulated and 58 miRNAs were significantly downregulated in PPD-treated nHHDPCs. Of note, the expression levels of miR-146b-5p were significantly downregulated by 30.17-fold following PPD treatment of the cells. miR-146b-5p has been previously reported to negatively regulate cellular senescence via targeting inter-leukin-1 receptor-associated kinase 1 in fibroblasts ([@b24-mmr-12-01-0921]). In addition, miR-378, which was downregulated by 36.78-fold in the present study, has been previously reported to promote cell survival, tumor growth and angiogenesis through targeting suppressor of fused and fused in sarcoma-1 ([@b25-mmr-12-01-0921]). Together, miR-146b-5p and miR-378 are known to be critical miRNAs involved in cell survival and anti-senescence; thus, regulation of their expression is a promising strategy for the treatment of PPD-mediated cellular senescence in dermal papilla cells. The biological functions of potential target genes of the altered miRNAs were further demonstrated using GO analysis and the web-based program DAVID. The target genes were categorized into four GO terms: Aging, skin development, apoptosis and cell proliferation. Additionally, KEGG pathway analysis identified that the target genes of the miRNAs upregulated by PPD treatment were predominantly implicated in the Wnt and MAPK signaling pathways. The Wnt signaling pathway has been demonstrated to maintain the balance between cell proliferation and differentiation ([@b26-mmr-12-01-0921]). Notably, the Wnt signaling pathway has an important involvement in hair follicle morphogenesis via activation of β-catenin ([@b27-mmr-12-01-0921]). In addition, in bald patients, activation of Wnt signaling was reported to induce reactivation of hair growth ([@b28-mmr-12-01-0921]). Therefore, the results of the KEGG pathway analysis in the present study indicated that PPD regulated hair growth, morphogenesis and proliferation of dermal papilla cells via miRNA-mediated regulation of the Wnt signaling pathway. MAPKs are important intracellular signaling molecules which have pivotal roles in proliferation, differentiation, development, transformation and apoptosis ([@b29-mmr-12-01-0921]). Therefore, the results of the present study suggested that PPD regulated MAPK signaling pathways through altering the expression of specific miRNAs, which in turn altered cell proliferation in dermal papilla cells.

In conclusion, to the best of our knowledge the present study was the first to use cell-based assays and miRNA microarray analysis to demonstrate that PPD significantly induced dermal papilla cell death and senescence through alteration of the expression levels of specific miRNAs. The results of the current study also suggested that the identified miRNAs may be potential candidates for the development of novel treatment strategies for PPD-induced cell dysfunction.
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![Effect of PPD on viability of nHHDPCs. nHHDPCs (5×10^3^) were seeded into 96-well plates and treated with various concentrations of PPD (0, 100, 200, 300, 400, 500 and 600 *μ*M) for 24 h. Cell viability was measured using the water-soluble tetrazolium salt assay. Values are presented as the mean ± standard error of the mean of the percentage of control optical density of experiments performed in triplicate. ^\*^P\<0.05 vs. 0 *μ*M PPD. PPD, para-phenylenediamine; nHHDPCs, normal human hair dermal papilla cells.](MMR-12-01-0921-g00){#f1-mmr-12-01-0921}

![PPD induced cell death and G~2~ arrest in nHHDPCs. nHHDPCs (2×10^6^ cells) were seeded into 60-mm culture dishes, treated with PPD (0, 200, 400 and 600 *μ*M) for 24 h, collected and stained with PI. (A) The fluorescence-intensity distribution of the stained cells was analyzed by flow cytometry. (B) The percentage of sub-G~1~ cells and the ratio of G~1~/G~2~ cells were then quantified. Sub-G~1~, G~1~, S and G~2~/M phases were separated using gates M1, M2, M3 and M4, respectively. ^\*^P\<0.05 vs. 0 *μ*M PPD. PPD, para-phenylenediamine; nHHDPCs, normal human hair dermal papilla cells; PI, propidium iodide.](MMR-12-01-0921-g01){#f2-mmr-12-01-0921}

![PPD increases intracellular ROS production and senescence in nHHDPCs. (A) nHHDPCs (2×10^6^ cells) were seeded into 60-mm culture dishes and treated with PPD (0 and 400 *μ*M) for 24 h. Cells were then collected and stained with DCF-DA solution. The fluorescence-intensity distribution of DCF-DA-stained cells was analyzed using flow cytometry. Alterations in the intracellular levels of ROS were determined using the M1 gate. (B) Senescence was measured using the senescence associated-β-galactosidase assay. nHHDPCs (2×10^6^) were seeded in 60-mm culture dishes and treated with PPD (0 and 400 *μ*M) for 48 h, fixed and then reacted with X-gal. ^\*^P\<0.05 vs. 0 *μ*M PPD. PPD, para-phenylenediamine; ROS, reactive oxygen species; nHHDPCs, normal human hair dermal papilla cells; DCF-DA, 2′,7′-dichlorodihydrofluorescein diacetate.](MMR-12-01-0921-g02){#f3-mmr-12-01-0921}

###### 

MicroRNAs exhibiting a ≥2-fold alteration in expression following treatment of normal human hair dermal papilla cells with *para*-phenylenediamine.

  MicroRNA       Fold change   Direction of regulation
  -------------- ------------- -------------------------
  miR-100-3p     57.90         Up
  miR-1225-3p    3.43          Up
  miR-1228-3p    2.14          Up
  miR-1238       2.34          Up
  miR-1825       2.08          Up
  miR-18b-3p     106.08        Up
  miR-191-3p     2.06          Up
  miR-3180-5p    100.21        Up
  miR-33b-3p     50.55         Up
  miR-425-3p     230.60        Up
  miR-4286       2.03          Up
  miR-4313       2.17          Up
  miR-4323       2.02          Up
  miR-634        2.26          Up
  miR-766-3p     3.78          Up
  miR-933        51.08         Up
  miR-410        2.48          Down
  miR-513a-5p    2.54          Down
  miR-500a       2.76          Down
  miR-3651       3.07          Down
  miR-1207-5p    3.14          Down
  miR-762        4.29          Down
  miR-150-3p     15.14         Down
  let-7a-3p      23.13         Down
  miR-1181       110.44        Down
  miR-1226-5p    32.72         Down
  miR-125a-3p    81.56         Down
  miR-128        45.79         Down
  miR-134        38.97         Down
  miR-138-2-3p   45.91         Down
  miR-146b-5p    30.17         Down
  miR-148b-3p    83.28         Down
  miR-17-3p      58.57         Down
  miR-181d       34.46         Down
  miR-185-5p     106.57        Down
  miR-195-5p     43.11         Down
  miR-197-3p     73.04         Down
  miR-202-3p     64.16         Down
  miR-214-5p     30.65         Down
  miR-23a-5p     17.14         Down
  miR-28-5p      50.28         Down
  miR-301a-3p    45.29         Down
  miR-30a-3p     64.02         Down
  miR-30e-3p     37.05         Down
  miR-324-5p     93.16         Down
  miR-342-3p     38.57         Down
  miR-3653       31.43         Down
  miR-3656       112.15        Down
  miR-3663-3p    89.50         Down
  miR-369-3p     45.40         Down
  miR-369-5p     42.07         Down
  miR-370        43.81         Down
  miR-371a-5p    15.21         Down
  miR-378        36.78         Down
  miR-3926       30.72         Down
  miR-409-5p     76.96         Down
  miR-423-5p     58.63         Down
  miR-4271       84.01         Down
  miR-4291       96.44         Down
  miR-431-5p     50.91         Down
  miR-431-3p     93.55         Down
  miR-4317       53.97         Down
  miR-487a       35.23         Down
  miR-501-5p     38.33         Down
  miR-505-3p     30.72         Down
  miR-513b       46.33         Down
  miR-539-5p     42.35         Down
  miR-548c-3p    19.22         Down
  miR-572        29.95         Down
  miR-642b-3p    68.28         Down
  miR-650        22.21         Down
  miR-660-5p     38.17         Down
  miR-770-5p     55.39         Down
  miR-874        53.92         Down

miR, microRNA.

###### 

Predicted targets of microRNAs upregulated in response to *para*-phenylenediamine treatment in normal human hair dermal papilla cells.

  MicroRNA          Biological processes and target genes                                                                                                                                                                                                     
  ----------------- ---------------------------------------- -------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  has-miR-100-3p    RPS6KB1, SLC1A2, RTN4                    LEF1, GNAS     NEUROD1, HIPK1, MDM2, RTN4, LEF1, SIX1, RILPL1, SKP2, RPS6KB1, GSDMA, PHF17, RTN3, MAP3K7, SON, MAPK31, ESPL1                                                                     LEF1, SIX1, MDM2, SAV1, BHLH41, AKIRN2, PDSSB, ODC1, SKP2, HIPK1, E2F3, RPOX1, NFIB, IRF2, TOB1
  has-miR-1225-3p   HMGA1, SREBF2, P2RY2                     --             EGLN3, LRP5, ESR1, BIRC5, CASP5, MEF2D, MAX, BMF, IL2, CLN3, AR, MAP3K1, IL2RB                                                                                                    KRT4, TGFBI, CD274, HDGF, EGLN3, LRP5, ESR1, BIRC5, IL2, IGFBP6, AR, RAPGEF3, CD34, GDF2, GFER
  hsa-miR-1228-3p   SLC32A1, AMFR                            --             EYA1, UBE2B, TJP1, MOAP1, AGAP2, PRDX2, WT1, BMP7, RNF41, CEBPG, CADM1, USP7                                                                                                      AGAP2, PRDX2, WT1, BMP7, THAP1, TSC1, PDCD1LG2, EYA1, WNT9A, MAPRE2, TNS3, LHX9, STAT6
  hsa-miR-1238      MSH6                                     APC            SIX1, THOC1, ING4, CCAR1, MSH6, APC, CTSH, BRCA1, SLIT3, ERCC3, API5                                                                                                              APC, ING4, CD160, SIX1, SP6, BLM, EPS8, BRCA1, TACC3, NASP, DPP4, CTSH, BCAT1, CNBP, PBX1, PTN, IGFBP5
  hsa-miR-1825      SERPINE1, RELA, ILK, LMNA, TERF2         DDR1, COL5A3   TM2D1, ROCK1, FXR1, MAX, SOS2, SERPINE1, RELA, ILK, HELLS, ITCH, SULF1, PKN2, LMNA, TRIM2, PDCD5, CECR2                                                                           SERPINE1, RELA, ILK, OSR1, DDR1, JAG1, KIT, SMARCA2, NRP1, PDPN, FANCA, PMP22, ITCH, PPARG, OSR1, TGFB2, ETS1, MAP3K11, PPARG, TIAM1, SULF1, ETS1, TGFB2, HELLS, MAP3K11, ACHE, FZD6, STAT6
  hsa-miR-18b-3p    HMGA2, SHC1,                             --             HMGA2, ITGB1, VHL, IP6K2, RAD21, DUSP6, RRP8, BCL2L2                                                                                                                              HMGA2, SHC1, ITGB1, VHL, ACVRL1, CIAO1, RPRD1B, EMP2 NAMPT
  hsa-miR-191-3p    --                                       --             HOXA5, GLI2                                                                                                                                                                       HOXA5, GLI2
  hsa-miR-3180-5p   CTNNA1, CTSC, CASP7, PTGS1, DCN, MGEA5   APC            CTNNA1, CTSC, CASP7, APC, GPAM, ERBB4, DLC1, NAE1, HOXA5, NAIP, DDX5, GAS2, BRCA1, HIPK2, SRPK2, NF1, ERBB2, MED1, CD38, STK4, MAP3K9, RBM25, TP53INP1, ROCK1, USP47, WNK3, BAX   HOXA5, NDRG2, KIF14, IRS1, ESRRB, BRCA1, NF1, SRPK2, FER, CTBP1, ST8SIA1, FKTN, PDPN, CD274, NFIB, ERBB2, STK4, GPAM, ERBB4, DLC1, MED1, PTGS1, HIPK2, APC, SESN1, CNBP, DOCK2, CDKN2B, FZD9, CDK13
  hsa-miR-33b-3p    RTN4                                     BCL11B         RTN4, DUSP22, DCUN1D3, BCL11B, PDE5A, FGFR1, UBE2Z, RPS3, URI1                                                                                                                    BCL11B, PDE5A, DUSP22, FGFR1. NAMPT, FOXF1, CD274, FEZF1, RPS15A, CHRM3
  hsa-miR-425-3p    --                                       --             --                                                                                                                                                                                --
  hsa-miR-4286      RELA                                     COL5A2         RELA, MED1, PTK2, PIM1, RRN3, MAP2K7, AGTR2, PSMD11, DYNLL2                                                                                                                       RELA, MED1, PTK2, PIM1, RRN3, DCNT2, FOXO4, ACVR2A
  hsa-miR-4313      --                                       --             TNFSF9, FZD5, JAK3                                                                                                                                                                TNFSF9, FZD5, JAK3, WNT3
  hsa-miR-4323      VDR, CTSC, MAP2K1                        --             VDR, CTSC, JAK3, PIM1, ID1, TAOK2, GSK3B                                                                                                                                          VDR, MAP2K1, JAK3, PIM1, TGFB1, GABBR1, MMP14
  has-miR-634       EDNRA, TGFBR1, RXRA, FURIN               --             EDNRA, RXRA, TRAF5, HRK, HIPK1, TGFBR1, NF1, RNF41, CXCR4, PDCD6IP, MAP2K4                                                                                                        FURIN, TRAF5, HIPK1, PIM1, EDNRA, CASK, ROGDI, NF1, TGFBR1, RXRA, ABI1
  hsa-miR-766-3p    CHEK2, TH, SCAP                          --             BDNF, NKX2 5, CUL5, SKP2, ESPL1, SLIT3, CARD8, DPF1, CHEK2, ESR2, MKL1, YARS, XAF1, KDM2B, PLEC                                                                                   ESR2, KDM2B, BDNF, NKX2 5, CUL5, SKP2, CAS8, STAT6, DOCK2, ABCB1, ERF
  hsa-miR-933       --                                       --             ING4, BDNF, MEF2A                                                                                                                                                                 ING4, BDNF

miR, microRNA; hsa, homo sapiens.

###### 

Predicted targets of microRNAs downregulated in response to *para*-phenylenediamine treatment in normal human hair dermal papilla cells.

  MicroRNA           Biological processes and target genes                                                                                                                                                                                                                                                                                          
  ------------------ ------------------------------------------------------------- ----------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  has-let-7a-3p      CNR1, TFRC, TGFBR1, F3, LRP2, ID2, VCAM1, SLC1A2              TCF7L2, JUP, ITGA2                  FOXO1, ITCH, TLR4, PDE5A, TGFBR1, F3, CNR1, TCF7L2, MALT1, SGK3, SOX2, CUL1, RHOA, HIPK2, CUL5, JAK2, IGF1R, MEF2C, LRP6, SMO, SKIL, ECT2, ROCK1, OPA1, ID1, PKN2, RNF34, CREB1, APP, HIP1, PAK2, RAD21, UBE2B, DSG2, SOS2   TLR4, PDE5A, MALT1, SGK3, MEF2C, SOX2, CUL1, IGF1R, CDC42, PLAG1, HHIP, NRP3, ID4, CDC73, NR5A2, PROX1, TOB1, RAX6, SNAI2, NR2F2, SALL1, NRP2, UTP20, EMP2, LRP6, SMO, PDSSB, MTSS1, TGFBR1, F3, VCAM1, LRP2, ID2, TCF7L2, RHOA, HIPK2, CUL5, JAK2, FOXO1, ITCH, TCF3, JAG1, FZD3
  hsa-miR-150-3p     TFCP2L1                                                       --                                  INHBA, IL1A, RHOA, ATG7, BCL3, MECOM, CRH, MPO, MAP3K5, NF1, ARHGEF7                                                                                                                                                         RHOA, NF1, PHOX2B, CD164, INHBA, IL1A, MECOM, EVI5, TIMELESS, FER, NDN, FYN, NRP1, BTRC
  hsa-miR-1181       --                                                            --                                  --                                                                                                                                                                                                                           --
  hsa-miR-1207-5p    RXRA, TERF1, WNT16, TMEM115, GNAO1                            DHCR24, TFAP2A, ATP7A               EDAR, ACAA2, GDNF, ALX4 DHCR24, TFAP2A, MAP2K5, PDPK1, ATG7, PACS2, TRIO, RXRA, PIM1, MSX1, IGF1R, ERBB2, PDE1B, BIRC6, CDH1, TERF1, APBB1                                                                                   MAFG, FOXO4, PBX1, RARA, ERBB2, RAC2, CSF1, MXD4, RXRA, DHCR24, TMEM115, IGF1R, PIM1, MSX1, BIRC6, TFAP2A, WNT16, MAP2K5, TSC2, TENC1, STAT6, MGFEB, SIX5
  hsa-miR-1226-5p    TBX3, EDNRA                                                   DDR1                                GLI2, DICER1, NF1, MLLT11, TBX3, EDNRA, PTK2, ING4, SKP2, RTN3, SORT1, PEG10, BCL2L2, EIF2AK3                                                                                                                                GLI2, DICER1, NF1, NACC2, IL9R, EMX2, HOXC10, SIX2, TBX3, EDNRA, PTK2, ING4, SKP2, SIX1, DDR1, TENC1, MLL2, FKTN
  hsa-miR-125a-3p    ULK3                                                          --                                  RHOA, TAOK1                                                                                                                                                                                                                  RHOA, TAOK1, TIRAP
  hsa-miR-128        EDNRA, MET, CNR1, SIRT1, F3, MAPK14, MNT, MME, TGFBR1, GRB2   APC, NGFR, COL5A1                   NGFR, PIK3R1, HIPK2, BMI1, CITED2, ERCC1, PHB, SIRT1, TGFBR1, CYLD, SLIT1, APC, DAPK1, SOS1, BTG2, CASP8, MAP2K4, MAGI3, PDPK1, MNT, CNR1, MAPK14, FOXO1, NTRK2, TRIM32, MCF2L, WNK3, FOXQ1, PLK2, GSK3B, BCL3               EIF2S2, FOXO4, NRP2, GAB1, SIRT1, TGFBR1, EDNRA, F3, ERCC1, PHB, CITED2, BTG2, RUNX1, SOX11, IRS1, TSC1, NRG1, ASPH, FOXP2, ZEB1, PRKX, JAG1, RAP1B, FZD3, HGF, HIPK2, FOXO1, BMI1, NTRK2, TRIM32, ADAM10, MNT, APC, NGFR, PIK3R1, FBXW7, VEFGC, EBI3
  hsa-miR-134        EDN1, CISD2                                                   COL5A2                              CXCR2, PAWR, TCHP, BDNF, EDN1, YAP1, STAT5B, PAX8, HIPK2, PDCD7, BARD1, SMAD6, CREB1, ITSN1                                                                                                                                  EDN1, YAP1, CXCR2, PAWR, CDK13, PKD2, OSMR, KRAS, HIPK2, BDNF, ASCC3, XCL1, STAT5B, MAGI2
  has-miR-138-2-3p   RPS6KB1, HMGA2, CHEK2, PNPT1                                  CTNNB1, APC, SHH                    CHEK2, APC, NF1, TP53INP1, FOXO3, MEF2C, SIX1, POLB, HIPK2, SHH, BCL2L1, SLIT3, HMGA2, HMGA2, RPS6KB1, BECN1, PEG3, RNF152, GSK3B                                                                                            NF1, HIPK2, BCL2L1, BECN1, HMGA2, HMGA2, APC, SHH, FOXO3, MEF2C, SIX1, TOB1, OTP, FER, FRK, PGR, WNT2, LHX9, CD34, E2F3, POU3F2, FGF5, PAX6, KLF5, PLAG1, STAT3, MBD2, CDK13
  hsa-miR-146b-5p    NOX4, SMC5, CCL5, LRP2, ATR                                   APC, ERRFI1, COL4A3                 CCL5, APC, ADAM17, CCK, COL4A3, ROBO1, SORT1, SIAH2, TRAF6                                                                                                                                                                   CCK, ERBB4, ROBO1, FZD3, CCL5, LRP2, NOX4, APC, ADAM17, CD80, HHIP, NRAS, SMAD4, NUMB
  hsa-miR-148b-3p    PTEN, RTN4, SCAP, UCP3, SERPINE1, MNT, IL15, LRP2, CANX       APC, ATP7A, COL2A1                  PPARG, MDM4, MITF, USP7, SULF1, IGF1, ROBO1, SOS1, ETS1, ROCK1, HIPK3, MAX, PTEN, SERPINE1, CDKN1B, MNT, RTN4, APC, COL2A1, SIK1                                                                                             PTEN, SERPINE1, MNT, IL15, MITF, CDKN1B, E2F7, NRAS, APC, PPARG, SULF1, MDM4, LRP2, ETS1, IGF1, ROBO1, FLT1, MXD1, CDK13
  hsa-miR-17-3p      PTEN, SERP1, TGFBR1, HMGA2, ICAM1, DLD                        BCL11B,                             PTEN, TGFBR1, BCL6, BDNF, HMGA2, BCL11B, MAPK1, PPARG, PIK3CA, TRIM2, MEF2C, DIDER, TOPOS, WNK3, TIA1                                                                                                                        PTEN, TGFBR1, BCL6, BDNF, HMGA2, BCL11B, MAPK1, MEF2C, DIDER, TOPOS, PPARG, TSC1, NF1B
  hsa-miR-181d       PTEN, ATM, RPS6KB1, VCAM, TIMP3, MME                          --                                  RPS6KB1, PTEN, ATM, CUL5, NOTCH2, GATA6, BCL6, BIRC6, CREB1                                                                                                                                                                  RPS6KB1, PTEN, ATM, CUL5, NOTCH2, GATA6, BCL6, BIRC6, RUNX1, VIP
  hsa-miR-185-5p     RELA, CDK6, MAPK14, ACAN                                      CDSN, EDA                           RELA, MAPK14, BRCA1, AR, MAP2K6, MED1, ERCC3, APP, PAK6, BCL2L2                                                                                                                                                              RELA, CDK6, MED1, BRCA1, AR, CDK2, BAI1, INSIG1
  hsa-miR-195-5p     BCL2, PDCD4, MAP2K1, MNT, DLD                                 WNT7A, ATP7A, EDA                   MNT, BCL2, PDCD4, WNT7A, NOTCH2, IGF1R, VEGFA, FOXO1, RAF1, BCL2L2, BFAR, SIAH1                                                                                                                                              RAF1, CCND1, FBXW7, E2F3, MNT, BCL2, MAP2K1, IGF1R, HMGA1, WNT7A, NOTCH2, VEGFA, FOXO1, ABCB1, FKBP1B
  hsa-miR-197-3p     TERT                                                          DDR1                                TERT, BRCA1, MAPK7, ING3, PSMD1, MEF2A                                                                                                                                                                                       BRCA1, DDR1, FTO, LHX9, ASCC3, PDGFRA, INSL4
  hsa-miR-202-3p     NOX4                                                          TFAP2B, ERRFI1                      TRAF5, YAP1, MEF2C, RAG1, DICER1, DUSP1, TRAF6                                                                                                                                                                               NOX4, TFAP2B, DICER1, TRAF5, YAP1, MEF2C, GPC3
  hsa-miR-214-5p     CDK6, KL, SLC1A2, TERF2                                       BCL11B, ERRFI1                      BCL11B, COL18A1, OSR1, RERP, E2F2, TP53I3                                                                                                                                                                                    CDK6, BCL11B, COL18A1, OSR1, DISC1, ABCB1, SMAD4, KLF5
  hsa-miR-23a-5p     P2RY2, DCN                                                    TFAP2C, WNT10A                      HSPA9, CLIP3, CARD8, NMT1                                                                                                                                                                                                    TLR4, FOXC1, ADAM10, CSF1, MAPRE1, NCK2
  hsa-miR-28-5p      --                                                            APC, CDSN                           APC, NF1, BAG1, WNK3                                                                                                                                                                                                         APC, NF1, SESN1, TRIM27
  hsa-miR-301a-3p    PTEN, EDN1, CDKN1A, LRP2, MET CANX, UCP3                      PTGES3, EDA                         IRF1, PRNP, RUNX3, ROBO1, SIK1, RAG1, ZMAT3, TRIM2, SULF1, USP28, SOS2, PAK6, EDN1, TGFA, MDM4, E2F2, PTEN, CDK5R1, CDKN1A, USP47, ROCK1, ROBO2                                                                              ROBO1, SULF1, USP28, TSC1, MDM4, PRNP, RUNX3, LIPA, MET, IRF1, TGFA, CDK5R1, WNT2B, HOXA3, RBFOX2, CDKN1A, PTEN, EDN1, E2F7
  hsa-miR-30a-3p     CACYBP, HMGA2,                                                --                                  PTEN, HMGA2, CDKN1B, MEF2C, BIRC6, TRIM2,                                                                                                                                                                                    CDKN1B, MEF2C, CREBBP, BLM, BIRC6, SUZ12,
  hsa-miR-30e-3p     PTEN                                                          --                                  CREB1, AKAP13, SOS1                                                                                                                                                                                                          PTEN, MXD1, ODZ1, HMGA2
  hsa-miR-324-5p     MSH6                                                          --                                  MSH6, VDAC1, PSME3                                                                                                                                                                                                           CTLA4, FYN, PBX1
  hsa-miR-342-3p     ADRB1, EDRNA, BCL2, CASP2                                     SOX21, EDA, COL5A2, COL1A2, TCF15   BRCA1, BCL6, BCL2L1, E2F1, BCL2, EDNRA, DAPK1, TIA1, NOTCH2, CASP2, ERBB4, PAK2, DUSP6, DRAM1                                                                                                                                BCL6, BCL2L1, E2F1, ERBB4, BCL2, NOTCH2, IRAK4, ID4, EDNRA, BRCA1, TACC1, CSF1, PGR, KAT2B
  hsa-miR-3651       MSH6                                                          --                                  MSH6, KLHL20, HIPK1                                                                                                                                                                                                          HIPK1, PRMT5
  hsa-miR-3653       HMGA2, PTEN, SOCS2                                            TFAP2C                              PTEN, HMGA2, SOCS2, MEF2C, SORT1, CREB                                                                                                                                                                                       PTEN, HMGA2, ADAM10, MEF2C, TFAP2C, RUNX1
  hsa-miR-3656       --                                                            --                                  --                                                                                                                                                                                                                           --
  hsa-miR-3663-3p    FAS, CASP2, CDKN1A, SREBF1                                                                        BCL11B, APC, ADAMTS2, COL1A1, COL3A1 CASP2, CDKN1A, DUSP2, COMP                                                                                                                                                              BCL11B, APC, USP28, DSG2, MEF2D, FAS, ARAF, PTH1R, APC, TGFB2, FABP1, CDKN1A, FAS, LIPG, CD80, BCL11B, USP28, DBN1, VSIG4, IL20RB
  hsa-miR-369-3p     SIRT1, WRN, MAP2K1, NUAK1, BRCA2, ADH5                        BCL11B, ATP7A,                      HDAC2, WRN, WNT5A, AHR, CARD11, JAK2, BMP2, XIAP, SATB1, PAWR, SOX2, FGF2, SOS1, OPA1, NDNF, MEF2D, SOX4, HGF, BIRC3, SLIT3, BRCA2, SIRT1, BCL11B, RASSF6, NEUROD1                                                           USP8, CEBPA, ODZ1, PROX1, CARD11, JAK2, BMP2, XIAP, MEGF10, FGF5, ZEB1, PAX6, SATB1, PAWR, SOX2, FGF2, SIRT1, MAP2K1, ADAM10, WNT5A, SOX4, AHR, HGF, NUAK1, BRCA2, HDAC2, CD47, ZEB2, VEGFC, WNT3
  hsa-miR-369-5p     --                                                            --                                  --                                                                                                                                                                                                                           --
  hsa-miR-370        PNPT1                                                         APC                                 APC, SMO, RAF1, CCL21, BFAR, PIK3CA, AKAP13                                                                                                                                                                                  APC, SMO, RAF1, PRTFDC1, FGF7, SMARCD3, CASK, SBDS, RXRB
  hsa-miR-371a-5p    --                                                            LEF1, ATP7A                         LEF1, STK4, CITED2, BARD1                                                                                                                                                                                                    LEF1, STK4, SOX2, COL8A1
  hsa-miR-378a-3p    --                                                            --                                  MNAT1, IGF1R, SKP2, NAE1                                                                                                                                                                                                     MNAT1, IGF1R, SKP2, TOB2
  hsa-miR-3926       INO80C                                                        --                                  TMX1, BIRC6, SATB1, IGF1R, CKAP2,                                                                                                                                                                                            TMX1, BIRC6, SATB1, IGF1R, CDK7, WDR6, ABCB1, ARNT
  hsa-miR-409-5p     --                                                            --                                  CREB1, NAIP                                                                                                                                                                                                                  UBE2L3, FGFR1OP
  hsa-miR-410        HMGA2, DCN, TOP2A, EDN1, SOCS3, CDK1, PTEN, ADM, LRP2, SMC5   --                                  BAG1, ELMO2, AHI1, MAGI3, HMGA2, EDN1 PTEN, SAV1, CD38, TIAL1, MDM2, BMP2, XIAP1, TBX5, FGF2, ARAF1, TOP2A, ETS1, BDNF, PTK2, PEG3, SNAI1                                                                                    HMGA2, CDK1, EDN1, PTEN, BDNF, PTK2, TIAL1, MDM2, COL4A3, NBN, XIAP, YAP2, ADM, LRP2, WNT16, EST1, ISL1, NUMB, TOB1, PEX2, E2F7, CBLB, FGF9, KLF5, IRS1, STAT3, LIFR, FST
  hsa-miR-423-5p     MSH6, GSN, PML, ILK, CASP2                                    --                                  CASP2, PML, ILK, APBB1, MSH6, GSN, LRP5, BAG1                                                                                                                                                                                PML, ILK, PTH1R, LRP5, BAP1, KDM4C, ELF4
  hsa-miR-4271       HMGA1, SLC6A3, AMFR                                           --                                  FOXO3, EI24, MEF2D, MAPT, SPN, CBX4, WNT7B, DAPL1, MAPK1, HMOX1, THRA                                                                                                                                                        WNT7B, FOXO3, SPN, MBD2, HMGA1, MAPK1, HMOX1, MXD11, MLL2, PDGFB, FOXO4, COL4A3BP
  hsa-miR-4291       VDR                                                           --                                  VDR, PIM1, DDX5, CREB1                                                                                                                                                                                                       VDR, PIM1, PGF, IRS1, MCC
  hsa-miR-431-5p     CANX                                                          TCF7L1                              TNFSF8, SOX9, IRS1, HIPK3                                                                                                                                                                                                    TNFSF8, SOX9, IRS2, NKX6 1
  hsa-miR-431-3p     --                                                            --                                  --                                                                                                                                                                                                                           --
  hsa-miR-4317       CTNNA1                                                        APC                                 CTNNA1, APC, IRS2                                                                                                                                                                                                            CTNNA1, APC, IRS2, ESR1
  hsa-miR-487a       SIRT1, CNR1, MARCH5                                           --                                  SIRT1, CNR1, TMX1, SGK3 BMI1, SGK3                                                                                                                                                                                           SIRT1, TMX1,
  hsa-miR-500a       MORC3                                                         --                                  AHR, BTG1, SULF1, HDAC2, ERBB3, SRGN, GRID2                                                                                                                                                                                  MORC3, AHR, BTG1, HDAC1, ERBB3, EMP1, SOX11, PRG4, FGF9, PEX2, AKIRIN2, BLM
  hsa-miR-501-5p     NR3C1, MAP2K1, TFRC                                           --                                  NR3C1, CUL1, MEF2C, BMI1, ING3, TMBIM4, TRIM39                                                                                                                                                                               NR3C1, CUL1, MEF2C, BMI1, MAP2K1, BCAT1, NOX1
  hsa-miR-505-3p     CHEK1                                                         --                                  TBX5, HMGB1                                                                                                                                                                                                                  TBX5, ATP8A2, IL11
  hsa-miR-513a-5p    PRKCD, NEK6, MORC3, MAP2K1, CDK6, ACAN, SERP1                 APC, SFN, WNT7A, TFAP2B             PRKCD, NEK6, APC, WNT7A, GATA3, XIAP, STAT1, MITF, BCL6, PPARG, ISL1, GZMB, MED1, HDAC2, SFN, EYA1, TRIO, SOS1, ECE1, VAV2, USP47, HGF, BCL2L11, WNK3, OCLN, MAL                                                             PRKCD, MORC3, CDK6, APC, SFN, WNT7A, TFAP2B, BCL6, PCM1, RXRB, PDXK, FOXP2, GATA3, STAT1, MITF, BTG1, HDAC2, XIAP, ISL1, MAGI2, MAP2K1, XRCC5, PPARG, E2F7, NFIB, VIP, ATF3, PURA, CSF1, KRAS
  has-miR-513b       TGFBR1, ID2, SIRT1, RNT4, ADH5                                BCL11B, TFAP2A, ATP7A               BCL2L1, PPARG, BMF, PAK6, TGFBR1, SIRT1, RNT4, PAK1, SNAI2, BCL11B, MOAP1, TCF7L2, ERBB4, XIAP, CREB1, API5, BCL2L11                                                                                                         TGFBR1, SIRT1, MARCKSL1, SNAI2, ERBB4, PAK1, XIAP, LIFR, FER, BCL11B, AGTR1, GATA2, VIP, BCL2L1, IRF2, ID2, FOXP2, WDR6, VTI1B
  hsa-miR-539-5p     SMC5, SLC1A2                                                  TCF7L2, TFAP2A                      CUL2, ERBB4, ELMO2, SET, TCF7L2, TFAP2A, HDAC2, TRIM2, PPARGC1A, SIX4                                                                                                                                                        ERBB4, FRS2, HDAC2, PBX1, TCF7L2, CUL2, CD47, DAB2, TFAP2A, VAX1, FKTN
  hsa-miR-548c-3p    NR3C1, PTEN, MORC3, SMC5                                      SHH, BCL11B, TCF7L2                 MITF, ERBB4, CITED2, XIAP, SGK3, TAOK1, RAG1, HIPK3, NR3C1, PTEN, SHH, TCF7L2, BTG1, LRP6, GATA6, REST, TIA1                                                                                                                 GATA6, REST, ERBB4, SGK3, NR3C1, PTEN, MORC3, SHH, ADAM10, FER, HHIP, KRAS, TCF7L2, BTG1, LRP6, MITF, CITED2, XIAP, SSR1, EREG, SOX11, RUNX1, PURA, E2F3
  hsa-miR-572        --                                                            --                                  --                                                                                                                                                                                                                           --
  hsa-miR-642b-3p    HMGA2, MET, CDKN1A, PTEN                                      BCL11B                              BCL11B, PDCD10, WT1, RB1, HMGA2, PTEN, CDKN1A, EIF2AK2, IFNG, MAPK8                                                                                                                                                          BCL11B, PDCD10, WT1, RB1, CDKN1A, NR2F2, PROX1, PTEN, EIF2AK2, HMGA2, PAX6, AMBN, PHOX2B
  hsa-miR-650        MADCAM1, SHC1                                                 --                                  LRP6, MITF, PIM1, CUL2, JAK3, MUL1, CSTB, AXL                                                                                                                                                                                SHC1, LRP6, MITF, PIM1, CUL2, JAK3, ERF, FTO
  hsa-miR-660-5p     --                                                            TFAP2B                              TFAP2B, BRCA1, HIPK1                                                                                                                                                                                                         TFAP2B, BRCA1, HIPK1, SF1
  hsa-miR-762        RELA, PML                                                     --                                  RELA, PML, MAPK1, MEN1, PAK4, ITCH, BCL6, PPARD, ADD1, PAX7, ITGB2, MYO18A                                                                                                                                                   RELA, PML, MAPK1, MEN1, PAK4, ITCH, BCL6, PPARD, MMP14, BAP1, FTO, WAR5, FSCN1, XIRP1. TENC1
  hsa-miR-770-5p     HMGA2, CNR1                                                   RYR1                                HMGA2, CNR1, MED1, SGK3, XAF1, HELLS, MAP3K1                                                                                                                                                                                 HMGA2, BTG1, LRP6, SGK3, HELLS, CCND2, MED1, PBX1, TSG101, NFIB
  hsa-miR-874        DDC                                                           --                                  ESR1, HIPK2, PAK7, THRA, SORT1                                                                                                                                                                                               RXRB, COMT, BMRP2, NPR1, ESR1, HIPK2, PAK7, CD276, MXI1

miR, microRNA; hsa, homo sapiens.

###### 

Main functions of upregulated microRNAs predicted using bioinformatics analysis.

  MicroRNA          Putative target genes   KEGG pathway                                      Genes involved in the term   \% involved genes   P-value
  ----------------- ----------------------- ------------------------------------------------- ---------------------------- ------------------- ----------
  has-miR-100-3p    167                     Pathways in cancer                                7                            4.2                 1.10E-02
                                            Ubiquitin mediated proteolysis                    5                            3.0                 8.00E-03
                                            Melanogenesis                                     4                            2.4                 2.00E-02
                                            Cell cycle                                        4                            2.4                 3.60E-02
                                            Wnt signaling pathway                             4                            2.4                 5.80E-02
  hsa-miR-1225-3p   183                     MAPK signaling pathway                            7                            3.8                 6.20E-02
                                            Neurotrophin signaling pathway                    5                            2.7                 4.20E-02
                                            Cell adhesion molecules                           5                            2.7                 5.10E-02
  hsa-miR-1228-3p   198                     Wnt signaling pathway                             4                            2.0                 1.30E-01
                                            MAPK signaling pathway                            4                            2.0                 3.80E-01
  hsa miR-1238      130                     --                                                --                           --                  --
  hsa miR-1825      321                     Pathways in cancer                                9                            2.8                 6.90E-02
                                            MAPK signaling pathway                            8                            2.5                 6.40E-02
  hsa-miR-18b-3p    108                     Long term potentiation                            4                            3.7                 3.80E-03
                                            Natural killer cell mediated cytotoxicity         4                            3.7                 2.40E-02
                                            Calcium signaling pathway                         4                            3.7                 4.80E-02
  hsa-miR-191-3p    11                      --                                                --                           --                  --
  hsa-miR-3180-5p   489                     --                                                --                           --                  --
  hsa-miR-33b-3p    121                     Neuroactive ligand receptor interaction           5                            4.1                 6.10E-02
                                            Calcium signaling pathway                         4                            3.3                 8.40E-02
  hsa-miR-425-3p    8                       --                                                --                           --                  --
  hsa-miR-4286      87                      Glycosphingolipid biosynthesis                    2                            2.3                 6.30E-02
  hsa-miR-4313      57                      Arrhythmogenic right ventricular cardiomyopathy   3                            5.3                 2.60E-02
                                            Melanogenesis                                     3                            5.3                 4.20E-02
                                            Wnt signaling pathway                             3                            5.3                 8.90E-02
  hsa-miR-4323      153                     Axon guidance                                     5                            3.3                 2.10E-02
                                            ErbB signaling pathway                            4                            2.6                 3.40E-02
                                            GnRH signaling pathway                            4                            2.6                 4.60E-02
  hsa-miR-634       207                     GnRH signaling pathway                            5                            2.4                 4.10E-02
  hsa-miR-766-3p    357                     Tight junction                                    10                           2.8                 4.60E-04
                                            Viral myocarditis                                 8                            2.2                 2.00E-04
  hsa-miR-933       9                       --                                                --                           --                  --

miR, microRNA; hsa, homo sapiens; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK, mitogen-activated protein kinase; GnRH, gonadotropin-releasing hormone.

###### 

Main functions of downregulated microRNAs predicted using bioinformatics analysis.

  MicroRNA           Putative target genes   KEGG pathway                              Genes involved in the term   \% involved genes   P-value
  ------------------ ----------------------- ----------------------------------------- ---------------------------- ------------------- ----------
  has-let-7a-3p      626                     Pathways in cancer                        24                           3.8                 4.60E-04
                                             Regulation of actin cytoskeleton          15                           2.4                 1.20E-02
                                             Wnt signaling pathway                     13                           2.1                 4.20E-03
  has-miR-150-3p     184                     Wnt signaling pathway                     5                            2.7                 6.00E-02
                                             Oocyte meiosis                            4                            2.2                 9.30E-02
  has-miR-1181       2                       --                                        --                           --                  --
  has-miR-1207-5p    503                     Regulation of actin cytoskeleton,         11                           2.2                 2.50E-02
                                             MAPK signaling pathway                    11                           2.2                 8.60E-02
  has-miR-1226-5p    219                     --                                        --                           --                  --
  has-miR-125a-3p    42                      Glycerolipid metabolism                   2                            4.8                 7.70E-02
  has-miR-128        642                     MAPK signaling pathway                    22                           3.4                 1.50E-04
                                             Insulin signaling pathway                 13                           2.0                 1.50E-03
  has-miR-134        245                     Chemokine signaling pathway               7                            2.9                 1.70E-02
                                             Cytokine-cytokine receptor interaction    7                            2.9                 7.10E-02
                                             Jak-STAT signaling pathway                6                            2.4                 2.90E-02
                                             Calcium signaling pathway                 6                            2.4                 4.60E-02
  has-miR-138-2-3p   345                     Pathways in cancer                        14                           4.1                 3.90E-03
                                             MAPK signaling pathway                    11                           3.2                 1.60E-02
  has-miR-146b-5p    314                     --                                        --                           --                  --
  has-miR-148b-3p    454                     Pathways in cancer                        20                           4.4                 5.30E-04
  has-miR-17-3p      307                     MAPK signaling pathway                    10                           3.3                 1.30E-02
                                             Pathways in cancer                        9                            2.9                 9.60E-02
                                             Insulin signaling pathway                 7                            2.3                 1.20E-02
                                             mTOR signaling pathway                    6                            2.0                 8.20E-04
  has-miR-181d       286                     Insulin signaling pathway                 6                            2.1                 2.10E-02
  has-miR-185-5p     423                     Axon guidance                             10                           2.4                 5.70E-04
  has-miR-195-5p     506                     Pathways in cancer                        21                           4.2                 1.30E-03
                                             MAPK signaling pathway                    14                           2.8                 4.80E-02
                                             Wnt signaling pathway                     13                           2.6                 1.40E-03
                                             Insulin signaling pathway                 12                           2.4                 1.90E-03
                                             Cell cycle                                10                           2.0                 1.10E-02
                                             Ubiquitin mediated proteolysis            10                           2.0                 1.90E-02
  has-miR-197-3p     216                     Ubiquitin mediated proteolysis            6                            2.8                 1.10E-02
                                             Calcium signaling pathway                 5                            2.3                 9.90E-02
  has-miR-202-3p     223                     Axon guidance                             5                            2.2                 7.80E-02
  has-miR-214-5p     196                     Regulation of actin cytoskeleton          6                            3.1                 6.70E-02
  has-miR-23a-5p     99                      --                                        --                           --                  --
  has-miR-28-5p      157                     MAPK signaling pathway                    7                            4.5                 1.20E-02
  has-miR-301a-3p    470                     Regulation of actin cytoskeleton          13                           2.8                 1.30E-02
  has-miR-30a-3p     221                     Pathways in cancer                        9                            4.1                 3.70E-02
                                             ErbB signaling pathway                    5                            2.3                 1.90E-02
  has-miR-30e-3p     185                     Pathways in cancer                        8                            4.3                 5.70E-02
                                             Jak-STAT signaling pathway                5                            2.7                 8.10E-02
                                             ErbB signaling pathway                    4                            2.2                 6.40E-02
                                             Melanogenesis                             4                            2.2                 8.70E-02
  has-miR-324-5p     39                      --                                        --                           --                  --
  has-miR-342-3p     386                     Calcium signaling pathway                 9                            2.3                 2.60E-02
                                             TGF-β signaling pathway                   7                            1.8                 8.00E-03
  has has-miR-3651   57                      --                                        --                           --                  --
  has-miR-3653       87                      --                                        --                           --                  --
  has-miR-3656       10                      --                                        --                           --                  --
  has-miR-3663-3p    305                     MAPK signaling pathway                    12                           3.9                 5.90E-03
  has-miR-369-3p     743                     MAPK signaling pathway                    15                           2.0                 9.90E-02
  has-miR-369-5p     2                       --                                        --                           --                  --
  has-miR-370        260                     Pathways in cancer                        8                            3.1                 6.10E-02
                                             Chemokine signaling pathway               6                            2.3                 5.00E-02
  has-miR-371a-5p    216                     Wnt signaling pathway                     5                            2.3                 6.70E-02
  has-miR-378a-3p    101                     Pathways in cancer                        7                            6.9                 2.00E-02
  has-miR-3926       274                     --                                        --                           --                  --
  has-miR-409-5p     16                      --                                        --                           --                  --
  has-miR-410        852                     Pathways in cancer                        29                           3.4                 4.80E-04
                                             MAPK signaling pathway                    20                           2.3                 2.50E-02
                                             Wnt signaling pathway                     16                           2.0                 2.50E-03
  has-miR-423-5p     218                     Calcium signaling pathway                 6                            2.8                 2.20E-02
                                             MAPK signaling pathway                    6                            2.8                 9.80E-02
                                             Insulin signaling pathway                 5                            2.3                 3.50E-02
  has-miR-4271       247                     Chemokine signaling pathway               6                            2.4                 9.40E-02
  has-miR-4291       88                      --                                        --                           --                  --
  has-miR-431-5p     172                     Wnt signaling pathway                     5                            2.9                 2.70E-02
  has-miR-431-3p     2                       --                                        --                           --                  --
  has-miR-4317       67                      Vascular smooth muscle contraction        3                            4.5                 9.00E-02
  has-miR-487a       184                     MAPK signaling pathway                    7                            3.8                 4.90E-02
                                             Tight junction                            6                            3.3                 1.00E-02
  has-miR-500a       260                     Ubiquitin mediated proteolysis            7                            2.0                 8.50E-02
  has-miR-501-5p     179                     Ubiquitin mediated proteolysis            6                            3.4                 8.20E-03
  has-miR-505-3p     30                      --                                        --                           --                  --
  has-miR-513a-5p    773                     Pathways in cancer                        24                           3.1                 2.00E-02
                                             MAPK signaling pathway                    20                           2.6                 2.80E-02
                                             Focal adhension                           18                           2.3                 7.90E-03
                                             Regulation of actin cytoskeleton          17                           2.2                 3.00E-02
  has-miR-513b       557                     Neuroactive ligand-receptor interaction   12                           2.2                 8.60E-02
  has-miR-539-5p     340                     --                                        --                           --                  --
  has-miR-548c-3p    438                     Pathways in cancer                        17                           3.9                 2.20E-03
                                             Wnt signaling pathway                     12                           2.7                 4.70E-04
                                             Insulin signaling pathway                 9                            2.1                 9.90E-03
  has-miR-572        4                       --                                        --                           --                  --
  has-miR-642b-3p    180                     Pathways in cancer                        7                            3.9                 4.60E-02
                                             Cell adhesion molecules                   5                            2.8                 2.10E-02
  has-miR-650        151                     Glycerophospholipid metabolism            3                            2.0                 9.90E-02
  has-miR-660-5p     104                     Adipocytokine signaling pathway           3                            2.9                 7.70E-02
  has-miR-762        342                     Axon guidance                             10                           2.9                 3.80E-04
                                             MAPK signaling pathway                    9                            2.6                 9.40E-02
                                             Cell adhesion molecules (CAMs)            7                            2.0                 2.70E-02
                                             Cell adhesion molecules (CAMs)            7                            2.0                 2.70E-02
  has-miR-770-5p     171                     Neurotrophin signaling pathway            6                            3.5                 4.00E-03
                                             MAPK signaling pathway                    6                            3.5                 7.90E-02
  has-miR-874        99                      --                                        --                           --                  --

miR, microRNA; hsa, homo sapiens; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK, mitogen-activated protein kinase; Jak-STAT, Janus kinase-signal transducer and activator of transcription; mTOR, mammalian target of rapamycin; TGF-β, transforming growth factor-β.
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